Please turn JavaScript on
Labiotech.eu icon

Labiotech.eu

Subscribe to Labiotech.eu’s news feed.

Click on “Follow” and decide if you want to get news from Labiotech.eu via RSS, as email newsletter, via mobile or on your personal news page.

Subscription to Labiotech.eu comes without risk as you can unsubscribe instantly at any time.

You can also filter the feed to your needs via topics and keywords so that you only receive the news from Labiotech.eu which you are really interested in. Click on the blue “Filter” button below to get started.

Title: Labiotech.eu

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  0.82 / day

Message History

Labiotech's reader survey reveals what our audience wants, needs, and is interested in for 2026.

The post We asked, you answered: Labiotech’s 2026 reader survey results appeared first on


Read full story

Cancer Research Horizons' CBO Tony Hickson discusses why charity and pharma need each other now more than ever.

The post How Cancer Research Horizons is building the future of childhood cancer medicine...


Read full story

Discover how UCB’s pipeline strategy in 2026 is still focused on its core areas of immunology and neurology.

The post UCB’s pipeline strategy in 2026: Doubling down on immunology and neurology appeared first on


Read full story

In this article, we take a look at seven clinical-stage biotechs that are fostering R&D in the Duchenne muscular dystrophy therapeutic space.

The post Seven biotechs driving progress in Duchenne muscular dystrophy  a...


Read full story

The CBO CEO relationship shapes biotech deal success. Discover insights from 19 industry leaders on board alignment and partnering.

The post We asked 19 biotech leaders what breaks their deals. It wasn’t the science. appeared first on


Read full story